NovoSeven

Type: Product

Name: NovoSeven

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Earnings and Sales Rise at Novo Nordisk - Analyst Blog

Novo Nordisk (NVO) reported first quarter 2013 earnings of $1.94 per American Depository Receipt (ADR), up 32.5% from the year-ago period. Revenues in the first quarter of 2013 increased 14% in local currencies year over year.All growth rates mentioned ... [Published Quote.com India - May 02 2013]

Entities: NOVO NORDISK A/S, Victoza, Insulin, Tresiba

First reported May 01 2013 - Updated May 02 2013 - 2 reports

Novo Nordisk's Q1 Profit Up 28 Percent

Novo Nordisk announced Wednesday that first-quarter profit jumped 28 percent versus the year-ago period to 6 billion Danish kroner ($1.1 billion), boosted by higher sales of insulins and Victoza, beating analyst estimates of 5.8 billion kroner ($1 billion). ... [Published PharmaceuticalProcessing - May 01 2013]

Entities: NOVO NORDISK A/S, Insulin, Tresiba, Victoza

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Novo Nordisk Lifts Full Year Revenue Forecast After Q1 Profit Climbs 28%

Insulin maker Novo Nordisk A/S (NVO: Quote) Wednesday reported higher profit for the first quarter, aided by strong growth in sales of both Diabetes care and Biopharmaceuticals products. The company raised the low end of its revenue outlook for the y ... [Published RTTNews.com - May 01 2013]

Entities: NOVO NORDISK A/S, Insulin, Victoza, Tresiba

First reported Apr 22 2013 - Updated Apr 23 2013 - 1 reports

Hadassah-Hebrew University Medical Center at Ein Kerem

What Boston hospitals learned from Israel

Avraham Rivkind, the chief of surgery at Hadassah Medical Center in Jerusalem, has pioneered several medical techniques, including several that helped save victims of the Boston Marathon attacks. (Hadassah Medical Center)TEL AVIV (JTA) -- Minutes after ... [Published JTA - Apr 22 2013]

Entities: Israel, Hadassah-Hebrew University Medical Center at Ei..., Hadassah

First reported Feb 16 2013 - Updated Feb 16 2013 - 1 reports

Novo Nordisk launches NovoSeven with pre-filled syringe for fast bleeding control

Novo Nordisk, a global healthcare company, has launched NovoSeven, a pre-filled syringe that will support rapid treatment of bleeding episodes in haemophilia patients with inhibitors.NovoSeven with pre-filled syringe is a system designed to meet patients' ... [Published PharmaBiz - Feb 16 2013]

Entities: NovoSeven, NOVO NORDISK A/S, Hemophilia, European Medicines Agency

First reported Jan 05 2013 - Updated Jan 05 2013 - 1 reports

NOVOSEVEN RT (Coagulation Factor Viia (Recombinant)) Kit [Novo Nordisk]

Updated Date: Jan 4, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jan 05 2013]

Entities: NovoSeven, Factor VIIa, Recombinant

Quotes

CEO Lars Rebien Sørensen remarked "we are pleased with the strong sales in the first quarter...driven by our portfolio of modern insulins and Victoza." Quarterly revenue from modern insulins jumped 14 percent year-over-year to 9 billion kroner ($1...

Novo Nordisk's Q1 Profit Up 28 Percent [Published PharmaceuticalProcessing - May 01 2013]

...Mr Sorensen said "we are in a constructive dialogue with the FDA on how to resolve the issues raised" in the CRLs

Very strong quarter for Novo despite Tresiba setback in USA [Published Pharma Times - May 01 2013]

Lars Rebien Sørensen, CEO, said, "We are pleased with the strong sales in the first quarter of 2013 driven by our portfolio of modern insulins and Victoza...In the US, we are in a constructive dialogue with the FDA on how to resolve the issues raised in the Complete Response Letter for Tresiba and Ryzodeg."

Novo Nordisk Lifts Full Year Revenue Forecast After Q1 Profit Climbs 28% [Published RTTNews.com - May 01 2013]

"Novo Nordisk constantly strives to make advancements for patients. With this latest development we show our commitment to improve the lives of people with haemophilia in every way possible" said Paul Huggins, corporate vice president, Biopharm Global Marketing & Medical Affairs

Novo Nordisk launches NovoSeven with pre-filled syringe for fast bleeding control [Published PharmaBiz - Feb 16 2013]

More Content

sort by: Date \| Relevance
Alnylam Pharmaceuticals' CEO Presents at 2013 B... [Published Seeking Alpha - May 16 2013]
Earnings and Sales Rise at Novo Nordisk - Analy... [Published Quote.com India - May 02 2013]
Novo Nordisk's Q1 Profit Up 28 Percent [Published PharmaceuticalProcessing - May 01 2013]
Very strong quarter for Novo despite Tresiba se... [Published Pharma Times - May 01 2013]
Novo Nordisk Lifts Full Year Revenue Forecast A... [Published RTTNews.com - May 01 2013]
What Boston hospitals learned from Israel [Published JTA - Apr 22 2013]
The Tricky Business of Treating Massive Hemorrhage [Published Pharmacy Practice News - Apr 18 2013]
Novo Nordisk launches NovoSeven with pre-filled... [Published PharmaBiz - Feb 16 2013]
Novo Nordisk launches NovoSeven® with pre-fille... [Published Novo Nordisk A/S - Press Releases - Feb 15 2013]
Novo Nordisk launches NovoSeven® (recombinant c... [Published Novo Nordisk A/S - Press Releases - Feb 15 2013]
NOVOSEVEN RT (Coagulation Factor Viia (Recombin... [Published DailyMed Drug Label Updates for the last seven ... - Jan 05 2013]
Investigators examine U.S. Army's use of contro... [Published Topnews.in - May 17 2010]
Fact Sheet for Novo-Nordisk A/S [Published Able2Act - Jul 24 2008]